Pilot Trial of Humanized Monoclonal Antibody J591 in Patients With Progressive Androgen-Independent Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2009
At a glance
- Drugs J 591; J 591-radiolabelled
- Indications Prostate cancer
- Focus Pharmacokinetics; Therapeutic Use
- 16 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2008 New trial record.